36
Participants
Start Date
February 17, 2022
Primary Completion Date
May 1, 2026
Study Completion Date
August 1, 2028
Loncastuximab Tesirine
Administered by intravenous infusion
Dexamethasone
Taken orally or administered by intravenous infusion
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Fred Hutch, Seattle
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
ADC Therapeutics S.A.
INDUSTRY
Shayna Sarosiek, MD
OTHER